Comparison of the Risk of Surgical Site Infections Between Dressings Stopped at Postoperative Day 1 vs Dressings Stopped at Postoperative Day 6+/-1 After Elective Abdominal Surgery

NCT ID: NCT06569862

Last Updated: 2026-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

1288 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-06

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The daily changing of postoperative dressings is a widespread practice, often continuing until the 5th-7th day after surgery. In theory, dressings aim to reduce the risk of superficial surgical site infections (SSIs). However, several studies have suggested that early removal of the dressing does not significantly impact the rate of superficial SSIs, and this approach is now applied in clinical practice by several teams. A Cochrane review indicated that the absence of dressing does not appear to be harmful, though it emphasized the very low level of evidence provided and the need for high-quality randomized controlled trials. In this study, the investigators aim to provide high-level evidence on the effect of stopping dressings from the 1st postoperative day and the lack of impact on the risk of SSIs, to standardize practices and enable recommendations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elective Abdominal Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Postoperative day 1 dressing

After removing the dressing on day 1, no dressing change by a nurse is required.

Group Type EXPERIMENTAL

Postoperative day 1 dressing

Intervention Type PROCEDURE

The patient's dressing will be removed on the first day after surgery, leaving the incision exposed to air, with daily cleaning.

Postoperative day 6+/-1 dressing

Daily dressing changes should be performed according to standard nursing procedures until postoperative day 6 (+/-1)

Group Type OTHER

Postoperative day 6+/-1 dressing

Intervention Type PROCEDURE

The patient will have a daily dressing change according to the usual nursing procedures, including saline serum washing, until the sixth day (+/- 1 day) after surgery. This will be done while the patient is in hospital, or at home if discharged before the sixth day.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Postoperative day 1 dressing

The patient's dressing will be removed on the first day after surgery, leaving the incision exposed to air, with daily cleaning.

Intervention Type PROCEDURE

Postoperative day 6+/-1 dressing

The patient will have a daily dressing change according to the usual nursing procedures, including saline serum washing, until the sixth day (+/- 1 day) after surgery. This will be done while the patient is in hospital, or at home if discharged before the sixth day.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient of legal age (≥18 years)
* Scheduled for elective abdominal surgery requiring a skin incision of at least 4 cm long listed below:

All pancreatectomies, All hepatectomies, All splenectomies, All adrenalectomies, All bariatric surgeries, All gastric surgeries, including gastrectomy and reflux surgery, All parietal surgeries; ventral hernia repairs, inguinal or femoral hernia repairs, with or without mesh placement..

All small bowel resections, Laparotomy cholecystectomies, All duodenal surgeries, Right, transverse or left colectomy, by laparotomy or laparoscopy, provided that there is a skin incision for extraction of the surgical specimen, but without the presence or creation of a stoma Proctectomy but without the presence or creation of a stoma

* Class I or II (clean or clean-contaminated) according to the ALTEMEIER classification
* Affiliated in a Social Security scheme (beneficiary or entitled person, excluding AME)
* Have signed an informed consent form

Exclusion Criteria

* Presence or completion of a stoma
* Previous abdominal surgery in the month prior to inclusion
* Emergency surgery
* Outpatient surgery
* Closure by biological glue
* Active bacterial infection at the time of surgery or recent antibiotic therapy (up to 15 days before surgery)
* Neutrophil count \< 500/mm3 at time of surgery
* Grade B or C cirrhosis (Child-Pugh classification)
* Pregnancy
* Breast-feeding
* Patient under guardianship or curatorship
* Patient deprived of liberty by judicial or administrative decision
* Patient unable to perform perioperative care
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital de la Pitié-Salpêtriere - APHP

Paris, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sebastien GAUJOUX, Prof

Role: CONTACT

0184827972

Stéphanie LE BOT, Mme

Role: CONTACT

0184827450

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sébastien Gaujoux, Pr

Role: primary

0184827972

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP230859

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.